University of Innsbruck-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2024

  1. Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 95, Núm. 5, pp. 410-418

2021

  1. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease

    Neurology, Vol. 97, Núm. 14, pp. E1367-E1381

2017

  1. Clinical manifestations of the anti-IgLON5 disease

    Neurology, Vol. 88, Núm. 18, pp. 1736-1743

2016

  1. Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes

    Journal of Neurology, Vol. 263, Núm. 7, pp. 1349-1360